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ABSTRACT
Objectives To investigate the decision- making process of 
Chinese university students with respect to antibiotic use 
for upper respiratory tract infections (URTIs).
Design A cross- sectional questionnaire study.
Setting The participants recruited from six universities 
across all Chinese regions from September to November 
2015.
Participants A total of 2834 university students sampled 
across six Chinese regions who self- reported experiencing 
symptoms of URTI within the past month completed the 
survey.
Outcome measures The prevalence of decisions 
for treatment and antibiotic use for URTIs as well as 
knowledge about antibiotic use were measured by a self- 
administrated questionnaire. Using regular and multinomial 
logistic regression a nd adapted health belief model, we 
identified and measured a number of variables as potential 
risk factors for antibiotic misuse behaviours in order to 
explain and predict people’s treatment decisions and 
antibiotic use including knowledge, perceptions, access to 
antibiotics and cues to action.
Results Of the 2834 university students who self- 
diagnosed a URTI, 947 (33.4%) self- reported having 
taken antibiotics; among them, 462 (48.8%) used non- 
prescription antibiotics, which came principally from 
left- over prescriptions (29.0%) and over- the- counter 
purchases at retail pharmacies (67.3%). One in four who 
sought care pressured their doctors for antibiotics; all 
received them. Those who perceived greater severity of 
the disease, had access to antibiotics, perceived benefits 
of using antibiotics (for the common cold: adjusted OR 
(aOR)=2.55, 95% CI 1.93 to 3.38 or as anti- inflammatory 
drugs: aOR=1.35, 95% CI 1.12 to 1.63), and were cued 
to action (eg, seeing presence of fever: aOR=2.05, 95% 
CI 1.62 to 2.60 or self- diagnosing their current infection 
as severe: aOR=1.86, 95% CI 1.41 to 2.45), keeping 
antibiotics at home (aOR=2.27, 95% CI 1.83 to 2.81) and 
access to over- the- counter antibiotics (aOR=2.00, 95% CI 
1.63 to 2.45), were more likely to misuse antibiotics.
Conclusions Misconceptions of antibiotic efficacy 
and easy access to antibiotics—with or without a 
prescription—were associated with antibiotic misuse 
among Chinese university students, which calls for 
context- appropriate multifaceted interventions in order to 
effectively reduce antibiotic misuse.
INTRODUCTION
Acute upper respiratory tract infections 
(URTIs), widely known as ‘the common cold’ 
and caused by several families of viruses, are 
the most common infectious diseases.1 The 
use of antibiotics is unnecessary for treating 
URTIs, as most URTIs are viral whereas 
antibiotics neither expedite recovery from 
infections nor prevent complications.2–4 
Nevertheless, URTIs remain the most 
common reason for primary care seeking 
of antibiotics and antibiotic prescriptions in 
Strengths and limitations of this study
 ► Guided by the adapted Health Belief Model, this 
study identified risk factors influencing antibiotic 
use for upper respiratory tract infections (URTIs) in 
the Chinese context (eg, perceived efficacy of anti-
biotic use for URTIs and easy access to antibiotics), 
which can inform the design and development of 
community- based behavioural change interventions 
aiming to reduce antibiotic misuse.
 ► Heterogeneity exists in antibiotics- related knowl-
edge and in its relationship with use.
 ► This study used a large sample size, with a response 
rate of 96%, drawn from all six regions across China 
where respondents were evenly distributed across 
all demographic groups.
 ► Considering people may have multiple infections 
during the year and because our sampled population 
is generally younger, healthier and better educated 
than the general population, we anticipate antibiot-
ic misuse among the Chinese general population to 
be more prevalent and severe than what has been 
presented here.
 ► The differences among the six provinces of differ-
ent development levels from which the clustered 
samples of this study were drawn may be greater 
than those among individuals drawn from a random 
sample across the country—we have accounted for 
such variation at the province/university level in the 
analyses.
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many countries, including China, which has one of the 
highest reported per capita rates of antibiotics use glob-
ally at 138 g/person.5 Most Chinese antibiotic consump-
tion occurs in outpatient settings, often unnecessarily 
for URTIs, which is a critical driver of inappropriate and 
excessive antibiotic use in China.6 7 Despite the magni-
tude of antibiotic misuse in China, there is little evidence 
towards understanding how people make URTI treat-
ment decisions, and little effort has been made to apply 
health behaviour theories towards understanding such 
decision- making.
An individual’s medical decisions, such as antibiotic use 
for URTIs, are influenced by their attitudes and percep-
tions of the illness and treatment options while these 
attitudes and perceptions themselves are heavily influ-
enced by socioecological context.8–10 Adults may experi-
ence a URTI two to five times annually,1 making it so well 
recognised that, before consulting a physician, individuals 
commonly engage in self- diagnosis and decide a course 
of action—a majority of these self- recognised episodes 
were managed without seeking formal care.11 To date, a 
majority of studies on antibiotic use behaviours examine 
the issues from a traditional, knowledge- attitudes- practice 
perspective, assuming people would make more ‘risk- 
conscious’ choices if informed of risks that could easily 
have been avoided (ie, improved knowledge and aware-
ness leads to changes in practice). However, decision 
scientists argue that when people engage in healthcare 
decision- making, they focus on attaining a goal—curing 
of an illness.12 This thinking focuses on a positive rather 
than a negative outcome, where people accept the risks 
of drug resistance (for the immediate perceived benefits 
of antibiotic use) rather than intentionally taking risks.12
The 2019 British Medical Journal policy review of China’s 
10- year effort in health reform13 clearly pointed to a 
current research and intervention gap that demonstrates 
there has been no improvement in primary care settings, 
where most of the population resides and the majority 
of antibiotic use takes place. Further, recent meta- analysis 
showed that despite being younger and better educated 
than the general public, university students’ misuse of 
antibiotics has been a global health problem, especially 
in low- income and middle- income countries (LMIC).14 In 
China, university students represent the future opinion 
leaders and the next generation of parents, and there-
fore, could serve as an entry point for assessment and 
intervention to the future trajectory of antibiotic misuse 
in China. However, previous studies on Chinese university 
students were limited in scale to one school9 15 and/or 
one region9 15 16 and were not grounded in behavioural 
theories. In this study, we undertook a risk factor anal-
ysis for the public’s antibiotic misuse behaviours for 
informing effective intervention development. Risk 
factors were identified using the Health Belief Model 
with an aim to explain and predict health behaviours with 
respect to antibiotic use for URTIs. Specifically, with self- 
diagnosed URTI cases, we aimed to assess Chinese univer-
sity students’ (1) Antibiotic use. (2) Treatment decisions 
regarding care seeking and antibiotic use. (3) Prescrip-
tion outcomes after seeking formal care, with a focus on 
antibiotic demands.
METHODS
Population sample
We used a cluster random sampling method to recruit 
university students across six Chinese regions for a cross- 
sectional survey from September to November 2015. 
The single best comprehensive university17 in each of six 
sampled provinces in each region was identified as they 
represent educational elite, future opinion leaders and 
the next generation of parents of the country. Students 
attending these universities were eligible for enrolment. 
With assistance from school officials, class schedules 
were obtained the day prior to the survey. Classes were 
randomly selected from the timetable; every class had 
an equal chance of selection. All university students 
attending these classes were included. Over 95% of 
students in the selected classes completed the question-
naire; some students did not participate due to lacking 
a phone or laptop at the time of survey. Pilot tests indi-
cated the prevalence of URTIs among Chinese university 
students in the past month to be 25%–30%. To ensure 
an adequate sample size for the planned subgroup anal-
yses, we aimed to achieve a sample size per university of 
ca.1800 students. A total of 11 192 students completed 
the survey. Among them, 25.32% (n=2834) self- reported 
experiencing symptoms of URTI1—including cold 
(cough, runny/stuffy nose), fever, sore throat, head-
ache and influenza, either alone or in combination—
within the past month. These respondents were evenly 
distributed across all demographic groups and included 
in this study. Further details on the survey’s design and 
sampling methods have been previously described and 
published.10 18
Data collection
This study used a systematically developed question-
naire. Questions were tailored to the Chinese sociocul-
tural context, as informed by literature review,8 9 15 16 
behavioural theories, and qualitative interviews with stake-
holders and experts for face validity and content validity. 
A consent form was presented at the first section of the 
questionnaire and was signed by all participants, who 
were informed that participation was confidential, volun-
tary, could be terminated at any time, and that the ques-
tionnaire would take ~5 min to complete. The survey was 
developed using Wen Juan Xing—a popular web- based 
platform for professional electronic questionnaires and 
data collection—and delivered via WeChat, China’s most 
used communication application. The survey was finalised 
after a pilot test with 254 respondents to evaluate poten-
tial sources of response error and improve the instru-
ment. The reliability and validity fit the requirements.
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Behavioural frameworks
We adapted the Health Belief Model19 20 and the concep-
tual framework for analysis, as presented in figure 1. 
The study aims to understand the impact of individuals’ 
perception of illness and treatment on one’s decisions 
for antibiotic use while accounting for the complex inter-
play between factors at different levels of socioecological 
environment21 (ie, individual, interpersonal and soci-
etal). Knowledge relates to antimicrobial resistance (AMR) 
awareness, ability to identify antibiotics and misconcep-
tions. Perceptions involve expectations about the serious-
ness of the consequences of acquiring URTIs (ie, perceived 
severity) or the benefits of antibiotic treatment for URTI 
symptoms (perceived antibiotic efficacy). Cues to action are 
external determinants of health behaviours (eg, presence 
of symptoms).
Outcome variables
To assess the prevalence of antibiotic use for self- 
diagnosed URTIs, participants were first assessed based 
on whether or not they had used antibiotics (with or 
without a prescription) for the symptoms they experi-
enced. They were then categorised into three subgroups 
with respect to their treatment decisions for using antibi-
otics: no treatment or self- treated without antibiotics (reference 
group), self- treated with antibiotics, and sought formal care. 
Diagnostic outcomes of care seeking were categorised 
into three subgroups with respect to doctors’ prescribing 
decisions for antibiotics: no antibiotic prescription (reference 
group), unnecessary antibiotic prescriptions for URTI symp-
toms and inappropriate antibiotic prescriptions due to patients’ 
demands.
Exposure variables
Consulting the modified Health Belief Model for antibi-
otic use (figure 1), we included the following potential 
risk factors in our analyses:
1. Knowledge about antibiotics and resistance was measured by 
a series of factual statements related to AMR awareness 
(five items), ability to identify antibiotics (seven items) and 
misconception about the antibiotics as ‘anti- inflammatory 
drugs’ (one item).
2. Perceived severity of URTIs was measured by knowing that 
URTIs are self- limiting and will dissipate naturally.
3. Perceived antibiotic efficacy was measured by five factual 
statements about antibiotics’ efficacy to treat URTIs.
4. Cues to action: (a) self- diagnosed severity of currentinfection, 
measured by numbers of cold symptoms experienced. (b) Pres-
ence of fever.
5. Access to antibiotics was measured by two yes/no ques-
tions: (a) Keeping antibiotics at home in the past year. (b) 
Over- the- counter purchase of non- prescription antibiotics in 
the past year.
Additionally, considering the Chinese socioecological 
environment regarding healthcare decisions, data on (6) 
Point of care used for care seeking was collected, ranging 
from hospitals above county level, county level hospitals, 
township hospitals and private clinics.
Figure 1 Modified health belief model for public antibiotic use.
 o
n
 August 28, 2020 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2020-039332 on 24 August 2020. Downloaded from 
4 Lin L, et al. BMJ Open 2020;10:e039332. doi:10.1136/bmjopen-2020-039332
Open access 
Covariates
Sociodemographic characteristics were included as 
potential confounders for the association between each 
exposure and treatment decisions, including age, sex, 
household income, urbanicity, university major in medi-
cine, having at least one parent with medical background 
and region/province.
Statistical analysis
First, we described and summarised participants’ socio-
demographic characteristics and risk factors by treatment 
decision/behavioural outcomes. Second, we developed a 
flow diagram to show pathways of different medical deci-
sion outcomes with respect to antibiotic use for URTIs. 
Third, we described responses to different domains of 
knowledge about antibiotic use and resistance. Fourth, 
to examine the association between each risk factor and 
outcome, we applied logistic regressions to estimate the 
OR (95% CI) for ‘treatment with antibiotic for URTIs’ (vs 
‘no antibiotic use’). Last, we explored the associations with 
subgroups of antibiotic use for URTIs by self- medication 
and via formal care, and applied multinomial logistic 
regressions to estimate the relative risk ratio, RRR (95% 
CI) for (1) ‘self- treatment with antibiotics’ and ‘sought 
healthcare’ (vs ‘no treatment or self- medication without 
antibiotics’). For students who sought healthcare, we esti-
mated RRR (95% CI) for (2) ‘receiving (unnecessary) 
prescriptions without request’ and ‘receiving (inappro-
priate) prescriptions due to patients request’ (vs ‘without 
an antibiotic prescription’). For each outcome and 
exposure, we first fitted an unadjusted model, and then 
a full model adjusted for potential confounders. These 
confounders—identified via published studies8 9 15 16 on 
public’s antibiotic use—include: age, sex, household income, 
urbanicity, being a medical student or having at least one parent 
with a medical background, and hometown region of residence 
(university/province).
Indirect patient and public involvement
We did not directly include patient and public involve-
ment in this study, but the database used was developed 
with stakeholders, including the general public who had 
previously experienced URTIs.
Guidelines
The guidelines for observational studies in epidemiology 
(Strengthening the Reporting of Observational studies in 
Epidemiology (STROBE) checklist) were followed during 
the preparation of the manuscript.
RESULTS
Distributions of decisions for treatment and antibiotic use for 
URTIs
As presented in figure 2, when the 2834 university students 
with self- diagnosed URTIs were asked about their choice 
of treatment, 20.4% decided against treatment (n=579), 
54.5% decided to self- treat (with or without antibiotics, 
n=1545), and a quarter sought formal care (n=710, 
25.1%). A total of 947 students self- reported having taken 
antibiotics for URTI symptoms: 462 (48.8%) used non- 
prescription antibiotics and the rest obtained a prescrip-
tion. Non- prescription antibiotics came principally from 
left- over prescriptions (29.0%) and over- the- counter 
purchases from pharmacies (67.3%). One out of every 
four respondents who sought formal care admitted to 
pressuring their doctors for antibiotics (n=123, 17.3%), 
with a 100% success rate.
Knowledge and perceptions about antibiotic use and 
resistance
Respondents were assessed on their knowledge about 
antibiotic use and resistance and perceptions on anti-
biotic efficacy and URTIs as a health threat. In table 1, 
the overall Cronbach’s alpha, including all items, was 
0.81, with subscales of 0.71 (for AMR awareness) and 
0.81 (for ability to identify antibiotics). Three quarters 
of participants (74.2%–88.5%) reported being aware of 
the dangers posed by overuse of antibiotics. A majority 
of participants (63.0%) had trouble distinguishing cold 
medicine (eg, Tylenol, Contac NT or Gankang) from 
antibiotics; 36.5% were unaware antibiotics were not anti- 
inflammatory drugs; more than 60% had an incorrect 
perception of antibiotic efficacy for URTIs, either being 
unsure or wrongly stating that antibiotics might expedite 
recovery or alleviate symptoms.
Factors associated with antibiotic use for URTIs
Compared with those who did not use antibiotics for treat-
ment of URTIs (see table 2), ability to identify antibiotics 
(adjusted OR (aOR)=1.51, 95% CI 1.17 to 1.94), perceived 
antibiotics to be effective for the common cold (aOR=2.55, 95% 
CI 1.93 to 3.38) or as anti- inflammatory drugs (aOR=1.35, 
95% CI 1.12 to 1.63), not knowing that the common cold is 
self- limiting (aOR=1.35, 95% CI 1.12 to 1.62), presence of 
fever (aOR=2.05, 95% CI 1.62 to 2.60), multiple symptoms 
experienced (aOR=1.86, 95% CI 1.41 to 2.45)), keeping anti-
biotics at home (aOR=2.27, 95% CI 1.83 to 2.81) and access 
to over- the- counter antibiotics (aOR=2.00, 95% CI 1.63 to 
2.45) were associated with a higher likelihood of antibi-
otic use for URTIs.
Factors associated with the treatment decisions for URTIs and 
antibiotic use
Relative to those who did nothing or self- treated without 
antibiotics for URTIs (reference group in table 3), partici-
pants who self- medicated with antibiotics were more likely 
to have perceived antibiotic efficacy for URTIs (adjusted rela-
tive risk ratio (aRRR)=3.03, 95% CI 2.10 to 4.38), mistake 
antibiotics as anti- inflammatory drugs (aRRR=1.40, 95% CI 
1.10 to 1.77), not know that the common cold is self- limiting 
(aRRR=1.34, 95% CI 1.05 to 1.71), experience multiple cold 
symptoms (aRRR=1.96, 95% CI 1.36 to 2.84), keep antibiotics 
at home (aRRR=4.68, 95% CI 3.24 to 6.74) and purchase 
over- the- counter antibiotics (aRRR=3.21, 95% CI 2.34 to 
4.41). Those who sought formal care were more likely to 
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have a high level of AMR awareness (aRRR=0.61, 95% CI 
0.42 to 0.89), have not known that URTIs are self- limiting 
(aRRR=1.66, 95% CI 1.36 to 2.02), experienced multiple cold 
symptoms (aRRR=1.64, 95% CI 1.21 to 2.21) and had pres-
ence of fever (aRRR=2.98, 95% CI 2.32 to 3.83). Participants 
who had perceived antibiotics to be effective for the common cold 
(aRRR=1.89, 95% CI 1.38 to 2.57), kept antibiotics at home 
(aRRR=1.24, 95% CI 1.00 to 1.54) and purchased over- the- 
counter antibiotics (aRRR=1.22, 95% CI 0.99 to 1.51) were 
also more likely to seek formal care.
Factors associated with antibiotic prescriptions for the 
treatment of URTIs
Participants who sought care and had high levels of AMR 
awareness had lower risks of demanding antibiotics. Rela-
tive to those who sought formal care but did not get an 
antibiotics prescription (reference group in table 4), 
participants who had high ability to identify antibiotics 
(aRRR=6.35, 95% CI 2.85 to 14.13), perceived antibiotics to 
be effective for the common cold (aRRR=3.67, 95% CI 1.61 to 
8.39) or as anti- inflammatory drugs (aRRR=1.92, 95% CI 
1.11 to 3.33), presence of fever (aRRR=3.24, 95% CI 1.70 to 
6.18), kept antibiotics at home (aRRR=2.46, 95% CI 1.33 to 
4.56) and made over- the- counter purchase (aRRR=3.69, 95% 
CI 1.97 to 6.91) had a higher likelihood of demanding 
antibiotic prescriptions. Evidence of structural differences 
was observed in antibiotic prescribing outcomes in point 
of care; 54.3% of patients who sought care at tertiary hospi-
tals and 52.7% at township hospitals were prescribed anti-
biotics for URTIs, whereas 43.2% of county hospitals and 
43.1% of local clinics gave antibiotic prescriptions for 
URTIs. All patients who demanded antibiotic prescrip-
tions from a doctor received them.
DISCUSSION
We found that 33.4% of young Chinese educated in 
top universities (n=947) with URTIs used antibiotics; 
among them, 462 (48.8%) used non- prescription anti-
biotics and additionally, a quarter of prescriptions orig-
inated from patients’ demands (n=123, 25.4%). We 
therefore estimated that the demand side is responsible 
for 61.8% of antibiotic use for URTIs ((462+123)/947). 
Surprisingly, high ability to identify antibiotics was linked to 
higher likelihoods of antibiotic use, especially antibiotic 
prescriptions. Mistaking antibiotics as anti- inflammatory 
drugs, perceiving antibiotics as efficacious for treating 
URTIs and access to non- prescription antibiotics were 
strongly associated with antibiotic misuse, including self- 
medication with antibiotics and demands for antibiotic 
prescriptions. We found non- prescription antibiotics are 
Figure 2 Medical decisions about antibiotic use for upper respiratory tract infections (URTIs) among Chinese university 
students.
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easily accessible in China: 68.2% of participants kept 
antibiotics at home at the time of the survey and 64.2% 
made over- the- counter purchases at least once within the 
past year. At health facilities, roughly 70% of clinicians 
prescribed antibiotics—most deemed as inappropriate 
and unnecessary—for URTI symptoms, and there was 
practically no barrier to accessing antibiotic prescriptions 
from a doctor.
Strengths and limitations
This study used a large sample size, with a response rate 
of 96%, drawn from all six regions across China where 
respondents were evenly distributed across all demo-
graphic groups. As of today, the survey provided the most 
recent, nationwide data of its kind. This study is guided by 
the adapted Health Belief Model for analysis in explaining 
and predicting patients’ treatment decisions and antibi-
otic use for URTIs. We found perceived infection severity, 
efficacy of antibiotic use for URTIs, barriers/access to 
antibiotics and cues to action are determinants of higher 
likelihoods of antibiotic use for URTIs, with or without 
prescriptions. In the Chinese context, our data further 
identified the demands of the health system—rather than 
supply—as the driving force for outpatient antibiotic use 
for URTIs, with a 1.6:1 ratio (62% vs 38%), and that access 
to antibiotics, with or without a prescription, was extremely 
easy. This model can guide the design and development 
of behavioural change interventions which aim to reduce 
antibiotic misuse in the community, with a focus on the 
complex interplay between individual/interpersonal/
societal factors and individuals’ decisions on treatment 
and antibiotic use for URTIs. Compared with previous 
studies on similar populations in China9 15 16 and other 
low- and middle- income countries (LMIC),14 this study 
made a novel contribution to the field of AMR by rooting 
in a behavioural theory and conducting a holistic assess-
ment on individual self- diagnostic and treatment decision- 
making processes with respect to antibiotics for URTIs, 
including the interaction between doctors and patients.
Table 1 Knowledge and perceptions about antibiotic use and resistance score distribution (n=2834)
Yes No I don’t know Alpha
n (%) n (%) n (%) 0.81
AMR awareness 0.71
  1. Antibiotic overuse is a serious problem in China. 2168 (76.5) 51 (1.8) 615 (21.7)
  2. The more frequently people use antibiotics; the more difficult it will be 
to treat bacterial infections.
2270 (80.1) 262 (9.2) 302 (10.7)
  3. Antibiotic overuse may increase antibiotic resistance. 2509 (88.5) 184 (6.5) 141 (5.0)
  4. Antibiotic resistance will become a serious problem in China. 2102 (74.2) 61 (2.2) 671 (23.7)
  5. We will have few antibiotics to use in the future if we don’t use 
antibiotics properly.
2367 (83.5) 222 (7.8) 245 (8.7)
Ability to identify antibiotics 0.81
  1. Penicillin (amoxicillin) 2263 (79.9) 275 (9.7) 296 (10.4)
  2. Cephalosporin (cefaclor, ceftriaxone sodium) 1969 (69.5) 342 (12.1) 523 (18.5)
  3. Non- steroidal anti- inflammatory drugs (ibuprofen, aspirin) 1129 (39.8) 894 (31.6) 811 (28.6)
  4. Quinolones (norfloxacin, ofloxacin) 1306 (46.1) 600 (21.2) 928 (32.8)
  5. Acetaminophen (Tylenol, Contac NT, Gankang) 799 (28.2) 1049 (37.0) 986 (34.8)
  6. Macrolides (azithromycin, roxithromycin) 1669 (58.9) 331 (11.7) 834 (29.4)
  7. Steroids (dexamethasone, prednisone) 761 (26.9) 820 (28.9) 1253 (44.2)
Misconception about antibiotics
  1. Antibiotics are anti- inflammatory drugs. 575 (20.3) 1799 (63.5) 460 (16.2)
Perceived antibiotic efficacy on URTIs
  1. Antibiotics can speed up recovery from influenza. 1250 (44.1) 1081 (38.1) 503 (17.8)
  2. Antibiotics can relieve the symptoms of cold. 1384 (48.8) 943 (33.3) 507 (17.9)
  3. Antibiotics are necessary for treating sore throat. 978 (34.5) 1620 (57.2) 236 (8.3)
  4. Antibiotics are necessary for treating common cold (cough, runny 
nose).
687 (24.2) 1912 (67.5) 235 (8.3)
Perceived threat about URTIs
  1. Common cold is self- limiting and does not require medication as the 
symptoms will dissipate naturally.
1927 (68.0) 725 (25.6) 182 (6.4)
URTI, upper respiratory tract infection.
 o
n
 August 28, 2020 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2020-039332 on 24 August 2020. Downloaded from 
7Lin L, et al. BMJ Open 2020;10:e039332. doi:10.1136/bmjopen-2020-039332
Open access
Table 2 Logistic regression to assess factors associated with antibiotic use for upper respiratory tract infections (URTIs) 
among Chinese university students (n=2834)
All students with 
URTIs (n=2834) Antibiotic use for URTIs (n=947, 33.42%)§ P 
value*§N (%) N(%) OR (95% CI) Adjusted OR (95% CI)‡
Knowledge about antibiotics
AMR awareness 0.97
  Low 181 (6.39) 73 (7.71) Reference Reference
  Medium 571 (20.15) 210 (22.18) 0.86 (0.61 to 1.21) 1.02 (0.70 to 1.50)
  High 2082 (73.47) 664 (70.12) 0.69 (0.51 to 0.95) 0.99 (0.70 to 1.42)
Ability to identify antibiotics 0.002
  Low 806 (28.44) 226 (23.86) Reference Reference
  Medium 1267 (44.71) 470 (49.63) 1.51 (1.25 to 1.83) 1.37 (1.11 to 1.70)
  High 761 (26.85) 251 (26.50) 1.26 (1.02 to 1.57) 1.51 (1.17 to 1.94)
Perceived severity of the infection
Common cold is self- limiting 0.002
  Yes 1927 (68.00) 581 (61.35) Reference Reference
  No/I don’t know 907 (32.00) 366 (38.65) 1.57 (1.33 to 1.85) 1.35 (1.12 to 1.62)
Perceived antibiotic efficacy
Perceived antibiotic efficacy for URTIs <0.0001
  No/low 938 (33.10) 200 (21.12) Reference Reference
  Medium 1476 (52.08) 542 (57.23) 2.14 (1.77 to 2.59) 1.71 (1.39 to 2.10)
  High 420 (14.82) 205 (21.65) 3.52 (2.75 to 4.50) 2.55 (1.93 to 3.38)
Antibiotics are anti- inflammatory drugs 0.001
  No 1799 (63.48) 524 (55.33) Reference Reference
  Yes/I don’t know 1035 (36.52) 423 (44.67) 1.68 (1.43 to 1.97) 1.35 (1.12 to 1.63)
Cues to action
Severity of current infection (number of symptoms experienced) <0.0001
  Low (1 symptom) 1488 (52.51) 395 (41.71) Reference Reference
  Medium (two symptoms) 893 (31.51) 317 (33.47) 1.52 (1.27 to 1.82) 1.37 (1.13 to 1.67)
  High (three symptoms or 
more)
453 (15.98) 235 (24.82) 2.98 (2.40 to 3.71) 1.86 (1.41 to 2.45)
Fever <0.0001
  No 2235 (78.86) 638 (67.37) Reference Reference
  Yes 599 (21.14) 309 (32.63) 2.67 (2.22 to 3.21) 2.05 (1.62 to 2.60)
Barriers/access to antibiotics
Keeping antibiotics at home <0.0001
  No 900 (31.76) 179 (18.90) Reference Reference
  Yes 1934 (68.24) 768 (81.10) 2.65 (2.20 to 3.20) 2.27 (1.83 to 2.81)
Over- the- counter purchase of non- prescription antibiotics in the past year <0.0001
  No 1015 (35.82) 202 (21.33) Reference Reference
  Yes 1819 (64.18) 745 (78.67) 2.79 (2.33 to 3.34) 2.00 (1.63 to 2.45)
Sociodemographic characteristics
Age 21.13† (2.67) 1.02 (0.99 to 1.05) 1.00 (0.96 to 1.03) 0.79
Sex 0.44
  Male 1476 (52.08) 496 (52.38) Reference Reference
  Female 1358 (47.92) 451 (47.62) 0.98 (0.84 to 1.15) 1.07 (0.90 to 1.28)
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Though the cross- sectional study design limited us 
from drawing causal relationships between knowledge 
and practice of antibiotic misuse, it helped to generate 
causal hypotheses and offered several points for interven-
tion. Experiments, longitudinal studies or behavioural 
data are needed in the near future to avoid recall bias, an 
inherent limitation of self- reported survey data. Consid-
ering people may have multiple infections during the year 
and because our target population consisted of university 
students, who are generally younger, healthier and better 
educated than the general population, we anticipate anti-
biotic misuse among the Chinese general population to be 
more prevalent and severe than what has been presented 
here. Further, China is a vast and dynamic country; it is 
likely that some findings about this particular popula-
tion may have changed over the last 5 years, which put 
constraints on the generalisability of the findings. Future 
studies should assess feasibility and appropriateness 
of the intervention proposed to the target population 
before full- scale implementation. As an example, a feasi-
bility study conducted in rural Zhejiang in 2019 showed 
that findings from this study were applicable to its target 
population.22 Lastly, because the samples were clustered, 
the estimated standard errors used in significance tests 
may be biassed. In our case, samples were drawn from 
six universities across China, from provinces of different 
development levels; the differences among these prov-
inces might be greater than those among individuals 
drawn from a random sample across the country. We have 
accounted for such variation at the province/university 
level in the analyses.
All students with 
URTIs (n=2834) Antibiotic use for URTIs (n=947, 33.42%)§ P 
value*§N (%) N(%) OR (95% CI) Adjusted OR (95% CI)‡
Urbanicity of home town 0.07
  Rural 1644 (58.01) 505 (53.33) Reference Reference
  Urban 1190 (41.99) 442 (46.67) 1.33 (1.14 to 1.56) 1.20 (0.98 to 1.47)
Average household income (¥, monthly) 0.05
  >10 000 (>$1538) 496 (17.50) 147 (15.52) Reference Reference
  3001–10 000 ($462–$1538) 1503 (53.03) 470 (49.63) 1.08 (0.87 to 1.35) 0.92 (0.72 to 1.17)
  ≤3000 ($461) 835 (29.46) 330 (34.85) 1.55 (1.22 to 1.97) 1.21 (0.90 to 1.62)
Major in medicine 0.02
  No 2396 (84.54) 835 (88.17) Reference Reference
  Yes 438 (15.46) 112 (11.83) 0.64 (0.51 to 0.81) 0.73 (0.56 to 0.95)
Having at least one parent with medical background 0.47
  No 2524 (89.06) 836 (88.28) Reference Reference
  Yes 310 (10.94) 111 (11.72) 1.13 (0.88 to 1.44) 1.11 (0.84 to 1.46)
Region (University, Province) 0.001
  North (Nankai University, 
Tianjin)
417 (14.71) 121 (12.78) Reference Reference
  East (Zhejiang University, 
Zhejiang)
459 (16.20) 104 (10.98) 0.72 (0.53 to 0.97) 0.81 (0.58 to 1.14)
  Southwest (Guizhou 
University, Guizhou)
493 (17.40) 223 (23.55) 2.02 (1.53 to 2.66) 1.56 (1.15 to 2.13)
  Northwest (Lanzhou 
University, Gansu)
528 (18.63) 203 (21.44) 1.53 (1.16 to 2.01) 1.29 (0.95 to 1.74)
  South (Wuhan University, 
Hubei)
480 (16.94) 121 (12.78) 0.82 (0.61 to 1.11) 0.93 (0.67 to 1.28)
  Northeast (Jilin University, 
Jilin)
457 (16.13) 175 (18.48) 1.52 (1.14 to 2.02) 1.09 (0.79 to 1.49)
*Likelihood ratio tests for antibiotic use for URTIs.
†Mean (SD).
‡Adjusted for age, sex, household income, urbanicity, university major in medicine, having at least one parent with medical 
background and region/province.
§Bold values denote statistical significance at the p < 0.05 level.
AMR, antimicrobial resistance.
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Interpretation of findings
First, we found that individual awareness of the danger 
of AMR was high among students, yet such awareness did 
not translate into prudent antibiotic use. This might imply 
the existence of an externality associated with antibiotic 
use for treating infections; despite a high awareness of 
AMR, the risks AMR imposes on others are unlikely to be 
felt directly or immediately by either the consumer or the 
supplier of treatment. Findings from this study identified 
a significant positive correlation between ability to iden-
tify antibiotics and self- medication, prescriptions, and 
demand for antibiotics. Previous studies demonstrated 
‘successful experiences’ in the past for ‘curing’ a similar 
illness, and knowledge of the previously prescribed anti-
biotics could lead to improved ability to identify antibi-
otics and self- medicate with antibiotics (SMA), promoting 
antibiotic demand by patients, and leading to a cycle of 
overtreatment.15 23–27 Our data suggest heterogeneity 
exists in the ‘domain’ of knowledge about antibiotics 
and its relationship with antibiotic practices for URTIs. 
Without sufficient knowledge about correct antibiotic 
efficacy, appropriate care for URTIs, and using antibiotics 
only under professional supervision, simply improving 
the public’s ability to identify antibiotics alone could 
potentially cause greater misuse. Therefore, the common 
current practice28 29 of grouping multiple aspects of 
antibiotics- related or AMR- related knowledge, attitudes 
and beliefs, and even practices into one score might 
not fully capture the complexity of their various associa-
tions with antibiotic use behaviours. A blanket awareness 
campaign or a simple intervention on clear labelling of 
antibiotics is likely to fail without adapting to the local 
context—a finding consistent with the recent assessment 
of the WHO awareness campaign.30 We found strong 
evidence showing that demanding antibiotic prescrip-
tions was associated with household stockpiling and over- 
the- counter purchases of antibiotics. Interventions which 
target ‘demanders’ and ‘heavy misusers’ of antibiotics in 
the community and that correct the misperception of 
antibiotics’ efficacy for URTIs or as anti- inflammatory 
drugs might reduce misuse.
In our data, all the participants who asked for antibi-
otics successfully received them. Even with good inten-
tions,8 31–34 unrealistic patient expectations and pressure 
from patients or caregivers to prescribe antibiotics have 
been identified as major reasons why physicians prescribe 
antibiotics for self- limiting diseases.34–38 This indicates 
an urgent need for further training to help clinicians 
improve clinical skills and doctor- patient communication 
skills. Clinicians’ overprescribing in China—incentivised 
by financial profits for health facilities39—might have 
helped shape and reinforce common public mispercep-
tions of antibiotics as effective for URTIs, which, in turn, 
further perpetuating misuse. This study showed 68.2% of 
participants stored antibiotics, which mainly came from 
over- the- counter purchases and previous prescriptions. 
The effect of keeping antibiotics at home on antibiotic 
(mis)use in the community is as profound as the impact 
of unnecessary prescriptions for URTIs through formal 
care. Since 2011, China has implemented policies (such 
as banning over- the- counter purchases and capping anti-
biotic prescriptions at 20% for county hospitals and above 
and 30% for township hospitals) to control antibiotic 
misuse, but the success of such initiatives has been limited 
due to poor enforcement.40–45 In our data, about 70% of 
patients with URTI who sought care were prescribed anti-
biotics; among them, over 50% of the patients received 
antibiotic prescriptions without prompting and close to 
20% successfully obtained antibiotics through explicit 
requests. These data pointed to an urgent need for effec-
tive, context- tailored hospital stewardship programmes 
that improve adherence to clinical practice guidelines 
for antibiotic prescribing in China and enhance doctor- 
patient communication over antibiotic use. Consistent 
with other studies,9 33 46 47 over- the- counter sales of non- 
prescription antibiotics at community pharmacies were 
found across China. Enforcing regulations regarding 
the sale of antibiotics, pack- based antibiotic dispensing 
systems, and public educational interventions to reduce 
consumer- driven prescriptions and left- over prescrip-
tions could curb the main sources of antibiotics for self- 
medication use.
CONCLUSION
Determinants of medical decisions for antibiotic use and 
care seeking are complex. It is critical to consider the 
heterogeneity of culture, health systems, and social norms 
in the assessment and intervention of decision- making 
regarding antibiotic use. This study provided urgently 
needed evidence for future interventional studies to 
address the challenges posed by the demand side and to 
improve the Chinese general population’s antibiotic use.
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